Clinical Trial Update: Ferumoxytol-enhanced Magnetic Resonance Imaging [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for ferumoxytol-enhanced MRI in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Coronary Artery Disease | Phase 3 | Status: UNKNOWN